Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238,310 | 151,359 | 541,835 | 373,173 | 370,741 |
| Marketable Securities | 2,627 | N/A | N/A | N/A | N/A |
| Receivables | N/A | 3,496 | 18,171 | 52,328 | 155,691 |
| Inventories | 864 | 5,559 | 28,486 | 64,584 | 78,971 |
| Other current assets | 0 | 391,202 | 50,586 | 322,837 | 2,502 |
| TOTAL | $294,803 | $563,304 | $653,953 | $832,917 | $623,894 |
| Non-Current Assets | |||||
| PPE Net | 8,872 | 17,254 | 30,961 | 34,780 | 38,330 |
| Intangibles | 200,571 | 200,571 | 457,756 | 672,041 | 825,750 |
| Other Non-Current Assets | 337,440 | 91,854 | 562,541 | 255,778 | 397,731 |
| TOTAL | $546,883 | $309,679 | $1,051,258 | $962,599 | $1,261,811 |
| Total Assets | $841,686 | $872,983 | $1,705,211 | $1,795,516 | $1,885,705 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 53,749 | 255,473 | N/A |
| Accounts payable and accrued liabilities | 695 | 10,244 | 20,578 | 36,038 | 19,799 |
| Accrued Expenses | 57,716 | 95,197 | 66,838 | 128,558 | 159,252 |
| Other current liabilities | N/A | 70,051 | 87,025 | 94,315 | 210,422 |
| TOTAL | $58,411 | $175,492 | $244,625 | $534,247 | $403,823 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 16,435 | 19,863 | 14,350 |
| Other Non-Current Liabilities | 805,539 | 672,577 | 718,665 | 439,489 | 456,757 |
| TOTAL | $805,539 | $672,577 | $808,603 | $529,495 | $561,791 |
| Total Liabilities | $863,950 | $848,069 | $1,053,228 | $1,063,742 | $965,614 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,857 | 73,284 | 71,380 | 69,615 | 65,645 |
| Common Shares | 77 | 76 | 73 | 72 | 68 |
| Retained earnings | -1,380,724 | -1,257,356 | -548,983 | -429,865 | -77,109 |
| Other shareholders' equity | -4,592 | -5,199 | -5,997 | 3,509 | 2,054 |
| TOTAL | $-22,264 | $24,914 | $651,983 | $731,774 | $920,091 |
| Total Liabilities And Equity | $841,686 | $872,983 | $1,705,211 | $1,795,516 | $1,885,705 |